NVAX Q4 Deep Dive: Partnership-Led Strategy and Pipeline Transition Shape Outlook [Yahoo! Finance]
Novavax, Inc. (NVAX)
Last novavax, inc. earnings: 3/11 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.novavax.com/investor-relations
Company Research
Source: Yahoo! Finance
Its non-GAAP profit of $0.11 per share was significantly above analysts' consensus estimates. Is now the time to buy NVAX? Find out in our full research report (it's free). Novavax (NVAX) Q4 CY2025 Highlights: Revenue: $147.1 million vs analyst estimates of $93.49 million (66.6% year-on-year growth, 57.4% beat) Adjusted EPS: $0.11 vs analyst estimates of -$0.58 (significant beat) Adjusted EBITDA: $19.36 million (13.2% margin, 116% year-on-year growth) Operating Margin: 9.7%, up from -148% in the same quarter last year Market Capitalization: $1.82 billion StockStory's Take Novavax's third quarter reflected the continued impact of its strategic pivot from a single-product commercial focus to a partnership-driven and R&D-oriented model. Despite surpassing revenue expectations, the company's operating losses widened as it restructured and transferred commercial responsibility for Nuvaxovid to Sanofi. Management attributed the quarter's underperformance to ongoing cost re
Show less
Read more
Impact Snapshot
Event Time:
NVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVAX alerts
High impacting Novavax, Inc. news events
Weekly update
A roundup of the hottest topics
NVAX
News
- Novavax (NVAX) had its price target raised by HC Wainwright from $11.00 to $16.00. They now have a "buy" rating on the stock.MarketBeat
- Novavax to Participate in Upcoming Investor Conferences [Yahoo! Finance]Yahoo! Finance
- Novavax to Participate in Upcoming Investor ConferencesPR Newswire
- Krispy Kreme stock skyrockets by nearly 30%, Shake Shake rising [Yahoo! Finance]Yahoo! Finance
- Krispy Kreme stock skyrockets by nearly 30%, Shake Shake rising [Yahoo! Finance Canada]Yahoo! Finance Canada
NVAX
Earnings
- 2/26/26 - Beat
NVAX
Sec Filings
- 2/26/26 - Form 8-K
- 2/26/26 - Form 10-K
- 2/11/26 - Form SCHEDULE
- NVAX's page on the SEC website